UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Place des anti-angiogéniques dans le traitement des gliomes

Pratique neurologique - FMC, 2011, Vol.2 (2), p.71-76

Idbaih, A.

2011

Volltextzugriff (PDF)

Terapie molecolari mirate e antiangiogeniche nel trattamento dei glioblastomi

EMC - Neurologia, 2012-08, Vol.12 (3), p.1-14

2012

Volltextzugriff (PDF)

Avancées dans les tumeurs cérébrales primitives malignes de l’adulte : quels patients transférer en réanimation médicale?

Réanimation, 2015-07, Vol.24 (4), p.424-432

2015

Volltextzugriff (PDF)

Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels

Annals of oncology : official journal of the European Society for Medical Oncology, 2019, Vol.30 (1), p.155-156

2019

Volltextzugriff (PDF)

Mixed histiocytosis, a rare cause of stroke

Revue neurologique, 2015, Vol.171 (8-9), p.676-677

2015

Volltextzugriff (PDF)

Trattamento dei linfomi cerebrali primitivi

EMC - Neurologia, 2008-01, Vol.8 (3), p.1-9

2008

Volltextzugriff (PDF)

Achievements of international rare cancers networks and consortia in the neuro-oncology field

Current opinion in oncology, 2024-08, Vol.36 (6), p.554-559

2024

Volltextzugriff (PDF)

Unveiling the enigma of the blood–brain barrier in glioblastoma: current advances from preclinical and clinical studies

Current opinion in oncology, 2023-11, Vol.35 (6), p.522-528

2023

Volltextzugriff (PDF)

PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth

Cellular oncology (Dordrecht), 2021-12, Vol.44 (6), p.1257-1271

2021

Volltextzugriff (PDF)

Oligodendrogliomas: new insights from the genetics and perspectives

Current opinion in oncology, 2012-11, Vol.24 (6), p.687-693

2012

Volltextzugriff (PDF)

Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: secondary outcome of the randomized phase III EORTC 26101 study

Neuro-oncology practice, 2024-09

2024

Volltextzugriff (PDF)

Diagnostic and prognostic markers in gliomas

Current opinion in oncology, 2009-11, Vol.21 (6), p.537-542

2009

Volltextzugriff (PDF)

A novel tumor suppressor function of Kindlin-3 in solid cancer

Oncotarget, 2014-10, Vol.5 (19), p.8970-8985

2014

Volltextzugriff (PDF)

Molecular genetic markers as predictors of response to chemotherapy in gliomas

Current opinion in oncology, 2007-11, Vol.19 (6), p.606-611

2007

Volltextzugriff (PDF)

Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101

Neuro-oncology practice, 2022-08, Vol.9 (4), p.310-316

2022

Volltextzugriff (PDF)

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies

Oncotarget, 2016-04, Vol.7 (16), p.21556-21569

2016

Volltextzugriff (PDF)

Communications dédiées à la biologie des tumeurs cérébrales présentées lors de l'ASCO 2009

Neurologie.com, 2010-01, Vol.2 (s1), p.7-10

Idbaih, Ahmed

2010

Volltextzugriff (PDF)

Carte d'identité génétique des gliomes diffus de l'adulte

Neurologie.com, 2010-01, Vol.2 (1), p.20-21

Idbaih, Ahmed

2010

Volltextzugriff (PDF)

Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis

Hematological oncology, 2023, Vol.41 (4), p.762-767

2023

Volltextzugriff (PDF)

Chapter 9 - Role of multidrug resistance in glioblastoma chemoresistance: Focus on ABC transporters

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies, 2021, p.243-261

2021

Volltextzugriff (PDF)

Role of multidrug resistance in glioblastoma chemoresistance: Focus on ABC transporters

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies, 2021, Vol.15, p.243-261

2021

Volltextzugriff (PDF)

Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy

Neurology. Clinical practice, 2021, Vol.11 (3), p.e376-e378

2021

Volltextzugriff (PDF)

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report

Frontiers in immunology, 2022, Vol.13, p.918613-918613

2022

Volltextzugriff (PDF)

Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco

Asian Pacific journal of cancer prevention : APJCP, 2016, Vol.17 (5), p.2649

2016

Volltextzugriff (PDF)

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis

Case reports in endocrinology, 2019, Vol.2019, p.2719364-2719364

2019

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(22)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Place des anti-angiogéniques dans le traitement des gliomes

Terapie molecolari mirate e antiangiogeniche nel trattamento dei glioblastomi

Avancées dans les tumeurs cérébrales primitives malignes de l’adulte : quels patients transférer en réanimation médicale?

Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels

Mixed histiocytosis, a rare cause of stroke

Trattamento dei linfomi cerebrali primitivi

Achievements of international rare cancers networks and consortia in the neuro-oncology field

Unveiling the enigma of the blood–brain barrier in glioblastoma: current advances from preclinical and clinical studies

PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth

Oligodendrogliomas: new insights from the genetics and perspectives

Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: secondary outcome of the randomized phase III EORTC 26101 study

Diagnostic and prognostic markers in gliomas

A novel tumor suppressor function of Kindlin-3 in solid cancer

Molecular genetic markers as predictors of response to chemotherapy in gliomas

Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies

Communications dédiées à la biologie des tumeurs cérébrales présentées lors de l'ASCO 2009

Carte d'identité génétique des gliomes diffus de l'adulte

Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis

Chapter 9 - Role of multidrug resistance in glioblastoma chemoresistance: Focus on ABC transporters

Role of multidrug resistance in glioblastoma chemoresistance: Focus on ABC transporters

Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report

Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis

Aktive Filter

Suchergebnisse filtern